Literature DB >> 32265295

Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2).

Elena Lorente1, Miguel G Fontela1, Eilon Barnea2, Antonio J Martín-Galiano3, Carmen Mir1, Begoña Galocha1, Arie Admon2, Pilar Lauzurica1, Daniel López4.   

Abstract

The HLA-B*27:05 allele and the endoplasmic reticulum-resident aminopeptidases are strongly associated with AS, a chronic inflammatory spondyloarthropathy. This study examined the effect of ERAP2 in the generation of the natural HLA-B*27:05 ligandome in live cells. Complexes of HLA-B*27:05-bound peptide pools were isolated from human ERAP2-edited cell clones, and the peptides were identified using high-throughput mass spectrometry analyses. The relative abundance of a thousand ligands was established by quantitative tandem mass spectrometry and bioinformatics analysis. The residue frequencies at different peptide position, identified in the presence or absence of ERAP2, determined structural features of ligands and their interactions with specific pockets of the antigen-binding site of the HLA-B*27:05 molecule. Sequence alignment of ligands identified with species of bacteria associated with HLA-B*27-dependent reactive arthritis was performed. In the absence of ERAP2, peptides with N-terminal basic residues and minority canonical P2 residues are enriched in the natural ligandome. Further, alterations of residue frequencies and hydrophobicity profile at P3, P7, and PΩ positions were detected. In addition, several ERAP2-dependent cellular peptides were highly similar to protein sequences of arthritogenic bacteria, including one human HLA-B*27:05 ligand fully conserved in a protein from Campylobacter jejuni These findings highlight the pathogenic role of this aminopeptidase in the triggering of AS autoimmune disease.
© 2020 Lorente et al.

Entities:  

Keywords:  Ankylosing Spondylitis; Antigen Processing; HLA; HPLC; Immunology; Label-Free Quantification; Mass Spectrometry; Peptides

Year:  2020        PMID: 32265295      PMCID: PMC7261815          DOI: 10.1074/mcp.RA120.002014

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  57 in total

Review 1.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 2.  HLA-B27 misfolding and ankylosing spondylitis.

Authors:  Robert A Colbert; Tri M Tran; Gerlinde Layh-Schmitt
Journal:  Mol Immunol       Date:  2013-08-30       Impact factor: 4.407

3.  Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.

Authors:  Susana Infantes; Elena Lorente; Eilon Barnea; Ilan Beer; Alejandro Barriga; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

4.  Separate effects of the ankylosing spondylitis associated ERAP1 and ERAP2 aminopeptidases determine the influence of their combined phenotype on the HLA-B*27 peptidome.

Authors:  Adrian Martín-Esteban; Alejandro Sanz-Bravo; Pablo Guasp; Eilon Barnea; Arie Admon; José A López de Castro
Journal:  J Autoimmun       Date:  2017-01-04       Impact factor: 7.094

5.  Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Polymorphism Relevant to Inflammatory Disease Shapes the Peptidome of the Birdshot Chorioretinopathy-Associated HLA-A*29:02 Antigen.

Authors:  Carlos Alvarez-Navarro; Adrian Martín-Esteban; Eilon Barnea; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2015-04-19       Impact factor: 5.911

6.  An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides.

Authors:  Tomo Saric; Shih-Chung Chang; Akira Hattori; Ian A York; Shirley Markant; Kenneth L Rock; Masafumi Tsujimoto; Alfred L Goldberg
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

7.  Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides.

Authors:  Efthalia Zervoudi; Athanasios Papakyriakou; Dimitra Georgiadou; Irini Evnouchidou; Anna Gajda; Marcin Poreba; Guy S Salvesen; Marcin Drag; Akira Hattori; Luc Swevers; Dionisios Vourloumis; Efstratios Stratikos
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

8.  The Peptide Repertoire of HLA-B27 may include Ligands with Lysine at P2 Anchor Position.

Authors:  Shira Yair-Sabag; Valentina Tedeschi; Carolina Vitulano; Eilon Barnea; Fabian Glaser; Dganit Melamed Kadosh; Joel D Taurog; Maria Teresa Fiorillo; Rosa Sorrentino; Arie Admon
Journal:  Proteomics       Date:  2018-03-13       Impact factor: 3.984

9.  Infection breaks T-cell tolerance.

Authors:  M Röcken; J F Urban; E M Shevach
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

10.  Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation.

Authors:  Terry C C Lim Kam Sian; Saranjah Indumathy; Hanim Halim; Anja Greule; Max J Cryle; Paul Bowness; Jamie Rossjohn; Stephanie Gras; Anthony W Purcell; Ralf B Schittenhelm
Journal:  J Biol Chem       Date:  2019-11-18       Impact factor: 5.157

View more
  7 in total

1.  Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target-Guided Synthesis.

Authors:  Virgyl Camberlein; Charlotte Fléau; Pierre Sierocki; Lenong Li; Ronan Gealageas; Damien Bosc; Valentin Guillaume; Sandrine Warenghem; Florence Leroux; Melissa Rosell; Keguang Cheng; Laura Medve; Mathilde Prigent; Myriam Decanter; Catherine Piveteau; Alexandre Biela; Maxime Eveque; Julie Dumont; Anastasia Mpakali; Petros Giastas; Adrien Herledan; Cyril Couturier; Jörg Haupenthal; Laetitia Lesire; Anna K H Hirsch; Benoit Deprez; Efstratios Stratikos; Marlene Bouvier; Rebecca Deprez-Poulain
Journal:  Angew Chem Int Ed Engl       Date:  2022-08-19       Impact factor: 16.823

2.  Evolution of immune genes is associated with the Black Death.

Authors:  Jennifer Klunk; Tauras P Vilgalys; Christian E Demeure; Xiaoheng Cheng; Mari Shiratori; Julien Madej; Rémi Beau; Derek Elli; Maria I Patino; Rebecca Redfern; Sharon N DeWitte; Julia A Gamble; Jesper L Boldsen; Ann Carmichael; Nükhet Varlik; Katherine Eaton; Jean-Christophe Grenier; G Brian Golding; Alison Devault; Jean-Marie Rouillard; Vania Yotova; Renata Sindeaux; Chun Jimmie Ye; Matin Bikaran; Anne Dumaine; Jessica F Brinkworth; Dominique Missiakas; Guy A Rouleau; Matthias Steinrücken; Javier Pizarro-Cerdá; Hendrik N Poinar; Luis B Barreiro
Journal:  Nature       Date:  2022-10-19       Impact factor: 69.504

3.  ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides.

Authors:  Ioannis Temponeras; George Stamatakis; Martina Samiotaki; Dimitris Georgiadis; Harris Pratsinis; George Panayotou; Efstratios Stratikos
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

Review 4.  Metabolomic analysis in spondyloarthritis: A systematic review.

Authors:  Tianwen Huang; Yaoyu Pu; Xiangpeng Wang; Yanhong Li; Hang Yang; Yubin Luo; Yi Liu
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

Review 5.  The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease.

Authors:  Marcus Kenyon; Sinead Maguire; Anna Rueda Pujol; Finbar O'Shea; Ross McManus
Journal:  Rheumatol Int       Date:  2022-08-08       Impact factor: 3.580

6.  The Salivary Microbiota, Cytokines, and Metabolome in Patients with Ankylosing Spondylitis Are Altered and More Proinflammatory than Those in Healthy Controls.

Authors:  Longxian Lv; Huiyong Jiang; Ren Yan; Danyi Xu; Kaicen Wang; Qiangqiang Wang; Xiaoxiao Chen; Lanjuan Li
Journal:  mSystems       Date:  2021-06-22       Impact factor: 6.496

Review 7.  Understanding the Pathogenesis of Spondyloarthritis.

Authors:  Aigul Sharip; Jeannette Kunz
Journal:  Biomolecules       Date:  2020-10-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.